In 1957, new thrombosis in people receiving heparin was described, beginning recognition of what became known as heparin-induced thrombocytopenia. Later reports connected the condition with falling platelet counts and immune mechanisms. The discovery reminded clinicians that lifesaving anticoagulants also required careful monitoring.

The recognition of Heparin-Induced Thrombocytopenia in 1957 complicated narratives around medicine as pure rescue. Writers and educators began to explore the nuanced relationship between powerful remedies and their risks, emphasizing themes of attention, humility, and the complexities of medical ethics in their works.